{
    "2019-04-30": [
        [
            {
                "time": "2019-05-08",
                "original_text": "药明康德：A股IPO时承诺锁定一年的股份将于5月8日起上市流通",
                "features": {
                    "keywords": [
                        "解禁",
                        "股份",
                        "上市流通"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-08",
                "original_text": "[快讯]药明康德61442万股限售股5月8日解禁",
                "features": {
                    "keywords": [
                        "限售股",
                        "解禁",
                        "5月8日"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "药明康德2019首季盈利增33% 度股东合计坚持11.93%股份",
                "features": {
                    "keywords": [
                        "盈利增",
                        "首季",
                        "股东减持"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "药明康德一季度业绩增三成",
                "features": {
                    "keywords": [
                        "一季度",
                        "业绩增",
                        "三成"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "药明康德：一季度净利润同比增32.97%",
                "features": {
                    "keywords": [
                        "一季度",
                        "净利润",
                        "同比增"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-08",
                "original_text": "药明康德：7名股东拟合计减持不超11.93%的股份 减持市值高达123.54亿元",
                "features": {
                    "keywords": [
                        "减持",
                        "市值",
                        "11.93%",
                        "123.54亿元"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "各业务板块增长强劲 药明康德一季度业绩增三成",
                "features": {
                    "keywords": [
                        "业务板块",
                        "增长强劲",
                        "一季度",
                        "业绩增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "西南医药】药明康德（603259）：业务高速增长，投资收益助力实现强劲业绩",
                "features": {
                    "keywords": [
                        "业务高速增长",
                        "投资收益",
                        "强劲业绩"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}